Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F48G3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,049
Award facts
- Contract value 100% obligated
- $11,048.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,048.60 to Amerisourcebergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens on January 7, 2026, with an ultimate completion date of January 8, 2026. This award represents a firm fixed-price purchase with no set-aside designation, indicating competitive award. The place of performance is listed as Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System and other government healthcare agencies.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The award demonstrates the contractor's ongoing capability to fulfill federal pharmaceutical procurement requirements through open competition on the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F48G3?
SPE2DR26F48G3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F48G3 worth?
The government has obligated $11,049 on SPE2DR26F48G3.
Is contract SPE2DR26F48G3 an order under another contract?
Yes. SPE2DR26F48G3 is a delivery order under SPE2DR25D3304, an indefinite delivery contract.
Was contract SPE2DR26F48G3 competed?
The extent of competition for SPE2DR26F48G3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award